Trial Profile
Evaluation of botulinum toxin in the treatment of salivary disorder in patients with amyotrophic lateral sclerosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms SLA-TOX
- 04 Apr 2017 New trial record